Biolase News

Biolase | 8-K: Current report

May 6 16:10 ET

Biolase | 424B4: Prospectus

Apr 23 16:26 ET

Biolase | EFFECT: Others

Apr 23 06:04 ET

Biolase | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 19 17:11 ET

Biolase | 8-K: Current report

Apr 19 16:16 ET

Biolase | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 11 16:56 ET

Biolase | 424B3: Prospectus

Apr 4 12:40 ET

Biolase | EFFECT: Others

Apr 3 06:07 ET

Biolase | CORRESP: CORRESP

Mar 28 12:48 ET

Biolase | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 27 16:45 ET

Biolase | ARS: Annual Report to Security Holders

Mar 22 12:41 ET

Biolase | DEFA14A: Others

Mar 22 12:41 ET

Biolase | DEF 14A: Definitive information statements

Mar 22 12:41 ET

Biolase | 10-K: Annual report

Mar 21 22:20 ET

Biolase | 8-K: Current report

Mar 21 16:08 ET

Biolase | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 8 06:35 ET

Biolase | 8-K: Current report

Mar 5 06:08 ET

Biolase | 8-K: Current report

Feb 27 16:20 ET

Biolase | SC 13G: Statement of acquisition of beneficial ownership by individuals-S.H.N. Financial Investments Ltd.(9.9%)

Feb 23 16:11 ET

Biolase | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.

Feb 21 16:48 ET